🔴 BioLineRx is trading 8.3% down today amid broad market and biotech weakness

BioLineRx is trading at $1.72, down 8.27%, amid sharp weakness across markets and biotech.

• The supplied context reports the XBI down 5.19% and the Nasdaq down 5.27%; contemporaneous coverage also described biotech shares falling with the broader sell-off.
• No confirmed BioLineRx-specific announcement was identified for November 5. The latest reported company news concerns earlier GLIX1 presentations.